|
VolitionRx Limited (Volition), a multi-national epigenetics company, announces the completion of all validation and verification of the chemiluminescent immunoassay (ChLIA) version of its Nu.Q Vet Cancer Test with Fujifilm Vet Systems Co. Ltd (Fujifilm Vet Systems) in Japan, allowing use of full automation rather than manual plates in central laboratories.
Junichi Makino, president and representative director at Fujifilm Vet Systems, said: “We are excited to be the first in the world to utilize this centralized lab automation for the Nu.Q Vet Cancer Test, this is a big step forward from the current use of manual plates.
“Since our launch of the Nu.Q Vet Cancer Test in July 2024, there has been an incredible amount of interest amongst Japanese veterinarians, indeed the number of veterinary hospitals registered to use the test in Japan already exceeds 1,700.
“This automated test will enable a more rapid turnaround and high throughput to meet increasing demand.”
Dr. Jasmine Kway, chief executive officer of Singapore Volition added: “There are approximately seven million pet dogs in Japan. Given Fujifilm Vet System is a leading provider of diagnostic tests in this large market, it presents an exciting revenue opportunity for Volition.
“Cancer is the leading cause of adult canine deaths and earlier detection can improve outcomes. The Nu.Q Vet Cancer Test is an accessible and affordable screening tool for dogs to aid in early cancer detection.
”This automated test via the Immunodiagnostic Systems (IDS) i10 automated analyzer platform is the same platform Volition utilizes for its human products: Nu.Q Cancer, Nu.Q NETs and Nu.Q Discover, demonstrating the synergy across not only the Nu.Q technology platform but also between humans and dogs.”
Volition’s supply agreement enables Fujifilm Vet Systems to sell and perform the Nu.Q Vet Cancer Test throughout its network of central reference laboratories in Japan.
FujiFilm Vet Systems is a subsidiary of FujiFilm Holdings Corporation, listed on the Tokyo stock exchange under ticker 4901. FujiFilm Vet Systems provides testing services centered on health checkups to veterinary medical facilities nationwide with relationships throughout the estimated 11,000 veterinary medical facilities in Japan.
Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.
|